Buy Cassava Sciences Inc Stock | SAVA Stock Price & Latest News | Public
SAVA

Cassava Sciences Inc

$0.00 (0.00%)Today
    Small Market Cap

    About SAVA

    Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.03
    -0.06
    -0.08
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.07

    Actual EPS
    Q3 2020

    Stats

    Market Cap$278,09M
    Volume817
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.34
    1 Year Low$1.05
    Open$10.92
    High$11.53
    Low$10.34

    Buy any stock with any amount of money.

    Download the App
    Download the app